THE MARKET-ENTRY BLUEPRINT
Market entry is a sequence of informed decisions. Our blueprint connects the technical work, local responsibilities, and commercial planning.
PHASE 01
Define intended use, target markets, classification, and documentation gaps.
We begin with your intended use, existing authorizations, quality-system evidence, and proposed market. The output is a scoped brief and a view of documentation gaps.
PHASE 02
Agree the regulatory strategy, local structures, responsibilities, and milestones.
We map the appropriate regulatory pathway, the local importer or licence-holder arrangement, and the work needed to prepare a submission.
PHASE 03
Coordinate technical evidence, the dossier, and responses to authority queries.
We support dossier development, coordination with relevant partners, submission preparation, and query-response work. Authority review timelines vary.
PHASE 04
Plan distribution, procurement conversations, and post-registration responsibilities.
We connect registration readiness with distribution planning, institutional procurement needs, training, and post-registration responsibilities.
NIGERIA FIRST. A REGIONAL VIEW.
Medical device registration support, local market-entry strategy, and clinical engineering insight.
Market-entry assessment and coordination through verified in-country partners, including French dossier and importer arrangements where required.
Tell us your target marketYOUR NEXT CHAPTER
From a first regulatory question to a defined market-entry plan, start with a conversation.
Book a consultation